H Isomäki

Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis

H Isomäki, Timo Hakulinen, U. Joutsenlahti · Journal of Chronic Diseases · 1978 · 432 citations

Hematological Malignancy, Rheumatology, Lymphoid Neoplasia +11

Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis

Kaisa Granfors, Sirpa Jalkanen, O. Mäki‐Ikola et al. · The Lancet · 1990 · 310 citations

Inflammation, Rheumatology, Rheumatoid Disorder +11

Ten year mortality and causes of death in patients with rheumatoid arthritis.

O. Mutru, Markku Laakso, H Isomäki et al. · BMJ · 1985 · 265 citations · Full text

Rheumatoid Disorder, Rheumatology, Time 352 +15

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment [published erratum appears in Br J Rheumatol 1998 Oct;37(10):1142]

C J Hawkey, André Kahan, Klaus Steinbrück et al. · Lara D. Veeken · 1998 · 259 citations · Full text

Gastrointestinal Pharmacology, Gastroenterology, Pharmacotherapy +18

Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX- inhibiting Therapies (SELECT) trial in osteoarthritis

J. Dequeker, Christopher J. Hawkey, André Kahan et al. · Lara D. Veeken · 1998 · 225 citations · Full text

Efficacy Large-scale Evaluation, Gastrointestinal Pharmacology, Pharmacotherapy +18